Product Name |
Brinzolamide D5 Hydrochloride |
Alternate Names |
Brinzolamide Stable Isotopes, Stable Isotopes of Brinzolamide |
CAT No. |
CS-O-06447
|
CAS No. |
Not Available |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
425.00 g/mol |
Mol. For. |
C₁₂H₁₇D₅ClN₃O₅S₃
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Brinzolamide |
Purity |
99.26 |
Smileys |
O=[S]1(C(SC([S](N)(=O)=O)=C2)=C2[C@@H](NC([2H])([2H])C([2H])([2H])[2H])CN1CCCOC)=O.Cl |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Brinzolamide D5 Hydrochloride is a medication primarily used for the treatment of open-angle glaucoma and ocular hypertension. It belongs to the class of drugs known as carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor in the eye, thereby lowering the intraocular pressure.
Chemically, Brinzolamide D5 Hydrochloride is a deuterated derivative of brinzolamide, with five deuterium atoms replacing the hydrogen atoms in the molecule. The deuterated form of the drug has a longer half-life and improved pharmacokinetic properties compared to its non-deuterated counterpart.
The medication is administered as eye drops, with the recommended dosage being one drop in the affected eye(s) twice daily. It is important to follow the dosing instructions provided by the healthcare provider to ensure maximum effectiveness and avoid the risk of adverse effects.
Brinzolamide D5 Hydrochloride has been extensively studied for its safety and efficacy in clinical trials. It has been found to be well-tolerated by most patients, with the most common side effects being ocular discomfort, blurred vision, and a bitter taste in the mouth.
In conclusion, Brinzolamide D5 Hydrochloride is a valuable medication for the management of open-angle glaucoma and ocular hypertension. Its deuterated form offers improved pharmacokinetics, making it a preferred choice for many healthcare providers.